Cyclin D1 expression is regulated by the retinoblastoma protein.

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol (1995) 6.41

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol (1995) 6.26

Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A (1995) 3.95

Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol (1996) 3.50

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol (1999) 3.42

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol (1995) 3.16

Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol (1996) 3.15

Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci U S A (1994) 2.64

Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J (1995) 2.57

Cell type-specific effects of Rb deletion in the murine retina. Genes Dev (2004) 2.18

Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol (1998) 2.10

Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol Cell Biol (2000) 1.93

Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol (2000) 1.71

Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol Cell Biol (1999) 1.68

Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol (1998) 1.64

Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci U S A (1995) 1.61

Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. Br J Cancer (2006) 1.56

Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol (1995) 1.52

Cyclin D1 and human neoplasia. Mol Pathol (1998) 1.50

Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter. Mol Cell Biol (1995) 1.43

Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol (1995) 1.35

Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein. J Biol Chem (2003) 1.31

Sleeping Beauty transposase modulates cell-cycle progression through interaction with Miz-1. Proc Natl Acad Sci U S A (2006) 1.19

Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer. Proc Natl Acad Sci U S A (2010) 1.18

Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A (2012) 1.15

The cyclin D1b splice variant: an old oncogene learns new tricks. Cell Div (2006) 1.15

Differential expression of cyclin D1 in the human hair follicle. Am J Pathol (2003) 1.10

Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol (1999) 1.08

Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol (1998) 1.08

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway. Am J Pathol (2003) 1.07

Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. Neoplasia (2001) 1.05

Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Lett (2011) 1.04

Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol (1996) 1.03

The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters. J Virol (2009) 1.01

Gene expression profile of AIDS-related Kaposi's sarcoma. BMC Cancer (2003) 1.01

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome. Br J Cancer (1999) 1.00

Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Am J Pathol (1996) 0.98

Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun (2001) 0.97

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer (1995) 0.95

Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am J Pathol (1997) 0.94

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Br J Cancer (2001) 0.94

Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J (2005) 0.92

Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer (1998) 0.91

Cell cycle regulators and their abnormalities in breast cancer. Mol Pathol (1998) 0.91

Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer. Cancer Sci (2013) 0.90

The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer. Am J Pathol (2004) 0.88

6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer. Oncotarget (2013) 0.86

Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol (2005) 0.86

The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer (2000) 0.85

The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains. J Virol (1995) 0.85

Role of cyclins in neuronal differentiation of immortalized hippocampal cells. Mol Cell Biol (1997) 0.84

Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder. Mol Pathol (2003) 0.83

Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas. Clin Cancer Res (2015) 0.80

Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer (1998) 0.80

Oncogenic transformation of normal enterocytes by overexpression of cyclin D1. Dig Dis Sci (2003) 0.78

Repression of cyclin D1 expression does not contribute to initiation or maintenance of cell transformation by adenovirus type 5 E1. J Virol (1996) 0.77

G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation. Nucleic Acids Res (2016) 0.77

Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells. Clin Exp Metastasis (1998) 0.75

Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins. Virology (2016) 0.75

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79

Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol (1987) 26.70

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28

G1 events and regulation of cell proliferation. Science (1989) 9.73

Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev (1993) 8.03

A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature (1991) 7.98

Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev (1993) 7.40

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell (1989) 6.43

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73

Tumor suppressor genes. Science (1991) 5.72

Human D-type cyclin. Cell (1991) 5.47

Retinoblastoma protein switches the E2F site from positive to negative element. Nature (1992) 5.47

Physical interaction of the retinoblastoma protein with human D cyclins. Cell (1993) 5.31

The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell (1991) 4.69

Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (1989) 3.63

Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54

The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15

Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol (1992) 2.97

Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J (1991) 2.84

Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78

Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci U S A (1992) 2.43

Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol (1993) 2.37

The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol (1992) 2.21

Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J (1992) 2.11

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene (1994) 2.10

Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature (1992) 1.93

C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc Natl Acad Sci U S A (1990) 1.91

Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci U S A (1993) 1.84

Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics (1992) 1.70

Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem (1992) 1.66

Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc Natl Acad Sci U S A (1991) 1.63

Recognition of the adenovirus type 2 origin of DNA replication by the virally encoded DNA polymerase and preterminal proteins. EMBO J (1992) 1.52

The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J (1993) 1.39

Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J (1993) 1.24

Cellular localization and T antigen binding of the retinoblastoma protein. Oncogene (1992) 1.16

The Rb gene suppresses the growth of normal cells. Oncogene (1993) 0.95

Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis. Oncogene (1992) 0.88

Transcriptional complexity. Curr Biol (1993) 0.81

Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev (1993) 8.03

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature (2001) 6.73

Binding of a specific ligand inhibits import of a purified precursor protein into mitochondria. Nature (1986) 5.58

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78

Rapid destruction of human Cdc25A in response to DNA damage. Science (2000) 4.74

Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet (1990) 4.49

Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol (2001) 4.22

Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat Cell Biol (1999) 3.74

Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res (1997) 3.70

TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol (2001) 3.69

DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene (2007) 3.67

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol (1999) 3.42

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J (1999) 3.41

Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell (1992) 3.37

Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res (1993) 3.26

High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol (1995) 3.16

Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev (2001) 3.15

Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem (1979) 3.15

Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J (1999) 3.05

Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02

Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J Cell Sci (1994) 3.00

Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83

Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol (1993) 2.83

Cyclin D1 protein expression and function in human breast cancer. Int J Cancer (1994) 2.81

Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol (2001) 2.77

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet (2009) 2.76

Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71

CHK2 kinase--a busy messenger. Nat Rev Mol Cell Biol (2001) 2.68

Repression of cyclin D1: a novel function of MYC. Mol Cell Biol (1994) 2.67

Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature (1999) 2.63

Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim (1995) 2.63

Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci U S A (1995) 2.60

Pathways governing G1/S transition and their response to DNA damage. FEBS Lett (2001) 2.58

c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood (2001) 2.52

Helix packing in polytopic membrane proteins: role of glycine in transmembrane helix association. Biophys J (1999) 2.49

Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol (1996) 2.44

An alternative pathway for gene regulation by Myc. EMBO J (1997) 2.43

Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci U S A (1993) 2.31

Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone (2005) 2.30

Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol (1997) 2.27

Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol (1998) 2.23

Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res (1999) 2.17

Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet (1987) 2.13

Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry (1998) 2.13

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol (1994) 2.11

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene (1994) 2.10

Both ATP and an energized inner membrane are required to import a purified precursor protein into mitochondria. EMBO J (1987) 2.08

Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J Cell Biol (1994) 2.08

Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci (1989) 2.07

Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer (1987) 2.03

Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol (1987) 1.97

Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol (1996) 1.97

Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains. Science (1995) 1.94

Assembly of CNS myelin in the absence of proteolipid protein. Neuron (1997) 1.93

Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J (1995) 1.92

A precision measurement of the mass of the top quark. Nature (2004) 1.87

The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol (1996) 1.87

Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82

Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. Nat Struct Biol (1997) 1.80

European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect (2000) 1.80

Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol (2001) 1.79

Distinct localization and cell cycle dependence of COOH terminally tyrosinolated alpha-tubulin in the microtubules of Trypanosoma brucei brucei. J Cell Biol (1987) 1.78

The MONICA Augsburg surveys--basis for prospective cohort studies. Gesundheitswesen (2005) 1.76

Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy. Neuropediatrics (2007) 1.75

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol (1996) 1.75

Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol Cell Biol (2000) 1.74

Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72

The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer (1994) 1.71

Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer (1985) 1.71

Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: a randomised placebo-controlled patient and observer blind trial. Anaesthesia (2004) 1.71

Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy (2006) 1.70

Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res (1995) 1.68

Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study. Am Heart J (1997) 1.67